The role of soluble urokinase plasminogen activator receptor (suPAR) in patients with cancer: a review of the current literature
Aim Several biomarkers are currently used as diagnostic and prognostic tools in patients with cancer. Soluble urokinase plasminogen activator receptor (suPAR) is elevated in acute and chronic inflammatory procedures and several observational studies during the last 20 years have investigated its role in oncology. The purpose of this article was to ...
By Themistoklis Paraskevas, Francesk Mulita, Christos Michailides, Georgios-Ioannis Verras, Elias Liolis, Eleousa Oikonomou, Ioannis Perdikaris, Panagiotis Perdikaris, Konstantinos Bouchagier, Ioannis Panagiotopoulos, Dimitrios-Ioannis Kasartzian, Dimitrios Filis, Levan Tchabashvili, Despoina Spyropoulou, Dimitrios Velissaris
Mid-term outcomes in the treatment of retroperitoneal sarcomas: a 12-year single-institution experience
Aim To present the experience from collective data regarding patients with retroperitoneal sarcomas that have been operated in and followed up by the University General Hospital of Patras in Rion, Greece, between 2009 and 2020.Methods A retrospective analysis of adult patients treated at our hospital with a diagnosis of primary retroperitoneal sarc...
By Georgios-Ioannis Verras, Francesk Mulita, Konstantinos Bouchagier, Dimitrios Bousis, Dimitrios Kehagias, Elias Liolis, Ioannis Perdikaris, Dimitrios Filis, Panagiotis Perdikaris, Ioannis Panagiotopoulos, Ioannis Maroulis, Nikolaos Benetatos